Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01344031 | MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2018 | clinicaltrials |
| NCT01484015 | Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia | completed | Phase 1 | 70 | Wake Forest University Health SciencesOTHER | 1 | Jul 18, 2018 |
| clinicaltrials |
| NCT01937689 | Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer | completed | Phase 1 | 40 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT02361112 | Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer(BLTN-Ic) | completed | Phase 1 | 38 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT01246102 | AT13387 in Adults With Refractory Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01994369 | Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17) | completed | Phase 1 | 10 | University of PennsylvaniaOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT00892736 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | completed | Phase 1 | 98 | National Cancer Institute (NCI)NIH | 1 | Jun 29, 2018 | clinicaltrials |
| NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2018 | clinicaltrials |
| NCT00699491 | Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 13, 2018 | clinicaltrials |
| NCT02270372 | Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer | completed | Phase 1 | 22 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT00080665 | Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 12 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT03502395 | Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion | completed | Phase 1 | 80 | Assiut UniversityOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT00834678 | Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01624441 | Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 30, 2018 | clinicaltrials |
| NCT01520389 | Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment | completed | Phase 1 | 112 | Merrimack PharmaceuticalsINDUSTRY | 1 | Mar 21, 2018 | clinicaltrials |
| NCT03065010 | Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer | completed | Phase 1 | 6 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01750320 | Koning Breast Computed Tomography Guided Biopsy | completed | Phase 1 | 4 | Koning CorporationINDUSTRY | 1 | Mar 7, 2018 | clinicaltrials |
| NCT00707707 | Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 4 | Mar 6, 2018 | clinicaltrials |
| NCT01843725 | Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers(MOMENTUM1) | completed | Phase 1 | 37 | Jules Bordet InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT01367626 | Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions | completed | Phase 1 | 28 | Roxane LaboratoriesINDUSTRY | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01367652 | Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions | completed | Phase 1 | 28 | Roxane LaboratoriesINDUSTRY | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02882581 | Metformin in Breast Cancer, Visualized With Positron Emission Tomography | completed | Phase 1 | 7 | Aarhus University HospitalOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02014337 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | completed | Phase 1 | 37 | Corcept TherapeuticsINDUSTRY | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01145430 | Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 22, 2017 | clinicaltrials |
| NCT01605630 | Family Cancer Literacy to Promote Mammography Screening Among Navajo Women | completed | Phase 1 | 40 | Mayo ClinicOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT03376503 | Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients | completed | Phase 1 | 24 | Nanogen Pharmaceutical Biotechnology Joint Stock CompanyINDUSTRY | 1 | Dec 19, 2017 | clinicaltrials |
| NCT01477489 | Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer | completed | Phase 1 | 33 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 15, 2017 | clinicaltrials |
| NCT00998036 | Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors | completed | Phase 1 | 9 | Columbia UniversityOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT01009437 | Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer | completed | Phase 1 | 28 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 5, 2017 | clinicaltrials |
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00005023 | Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer | completed | Phase 1 | — | University of WashingtonOTHER | 1 | Nov 30, 2017 | clinicaltrials |
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | completed | Phase 1 / Phase 2 | 148 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT00620295 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00680667 | Clinical Trial of Trametes Versicolor in Women With Breast Cancer | completed | Phase 1 | 11 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 16 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00526617 | A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients | completed | Phase 1 | 41 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT01853306 | A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors | completed | Phase 1 | 71 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT02009631 | A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors | completed | Phase 1 | 45 | AbbVieINDUSTRY | 3 | Nov 20, 2017 | clinicaltrials |
| NCT00581256 | A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer | completed | Phase 1 / Phase 2 | 54 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01046929 | Limonene Study in Women With Breast Cancer | completed | Phase 1 | 59 | University of ArizonaOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT01508572 | VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer | completed | Phase 1 | 20 | University Medical Center GroningenOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT00976339 | Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer | completed | Phase 1 | 20 | Katherine D. CrewOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT02658708 | Bright Light on Fatigue in Women Being Treated for Breast Cancer | completed | Phase 1 | 19 | Washington University School of MedicineOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01918254 | A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein | completed | Phase 1 | 66 | Hoffmann-La RocheINDUSTRY | 4 | Sep 12, 2017 | clinicaltrials |
| NCT01650506 | Study of Erlotinib and Metformin in Triple Negative Breast Cancer | completed | Phase 1 | 8 | Columbia UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01263145 | MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02015416 | A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer | completed | Phase 1 | 13 | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 1 | Aug 17, 2017 | clinicaltrials |
| NCT02135159 | Patients With Brain Metastases From HER2-positive Breast Cancer(BIRTH) | completed | Phase 1 | 36 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Aug 14, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jul 23, 2018source: clinicaltrials